The NFκB pathway: a therapeutic target in glioblastoma

Cancer initiating cells have been described to be the only cell population with tumorigenic capacity in glioblastoma multiforme, one of the most aggressive and untreatable cancers. Recent work from our group described that NFκB pathway was activated in glioblastoma initiating cells undergo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nogueira, Lorena, Ruiz-Ontañon, Patricia, Vazquez-Barquero, Alfonso, Moris, Francisco, Fernandez-Luna, Jose L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2011
Materias:
Research Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248209/
https://www.ncbi.nlm.nih.gov/pubmed/21896960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248209/
https://www.ncbi.nlm.nih.gov/pubmed/21896960

Ejemplares similares